ArticleScientific reports2026
Low-MESF fluorescent reference particles for flow cytometry analysis of extracellular vesicles.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracellular vesicles (EVs) hold strong potential as non-invasive biomarkers for early detection of diseases. However, their clinically relevant quantitative flow cytometric (FCM) analysis remains limited by the lack of suitable calibration particles with low single-particle fluorescence values. Although fluorescent labeling of silica particles is well established, traditional approaches typically yield heterogeneous fluorophore distributions in the low MESF (Molecules of equivalent soluble fluorophore) range, which is required for single-EV fluorescence calibration. To this end, we introduce a labeling strategy that overcomes this limitation by using fluorescently tagged silica-binding peptides (R5-FITC) to produce submicron silica particles with homogeneous low-level fluorophore coverage. Silica particles of three different sizes were synthesized and labeled in a fast and straightforward manner. After comprehensive characterization, FCM investigations revealed that the resulting dim fluorescent silica particles (as low as 278 MESF with narrow distribution) are suitable for calibrating the fluorescence intensity of EVs isolated from red blood cells. Our findings show that fluorescent particles resembling EVs in both size and fluorescence can improve calibration accuracy and foster standardization in FCM-based EV characterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.